These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11315)

  • 1. Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites.
    Fuller RW; Perry KW; Clemens JA
    J Pharm Pharmacol; 1976 Aug; 28(8):643-4. PubMed ID: 11315
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats.
    Fuller RW; Snoddy HD; Clemens JA
    Pharmacol Res Commun; 1981 Mar; 13(3):275-80. PubMed ID: 7208571
    [No Abstract]   [Full Text] [Related]  

  • 3. Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1979 Mar; 31(3):183-4. PubMed ID: 34697
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and d-fenfluramine in rats. Relation to brain drug concentrations.
    Invernizzi R; Fracasso C; Caccia S; Di Clemente A; Garattini S; Samanin R
    Eur J Pharmacol; 1989 Apr; 163(1):77-83. PubMed ID: 2744095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased accumulation of brain 5-hydroxytryptophan after decarboxylase inhibition in rats treated with fenfluramine, norfenfluramine or p-chloroamphetamine.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1983 Sep; 35(9):597-8. PubMed ID: 6138413
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
    Hofmann M; Battaini F; Tonon G; Trabucchi M; Spano P
    Eur J Pharmacol; 1979 Jun; 56(1-2):15-20. PubMed ID: 467503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine.
    Duhault J; Boulanger M; Voisin C; Malen C; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures.
    Govoni S; Petkov VV; Montefusco O; Missale C; Battaini F; Spano PF; Trabucchi M
    J Pharm Pharmacol; 1984 Jul; 36(7):458-60. PubMed ID: 6146691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lithium on 3,4-dihydroxyphenylacetic acid (DOPAC) concentrations in different brain areas of rats.
    Fadda F; Serra G; Argiolas A; Melis MR; Gessa GL
    Pharmacol Res Commun; 1980 Jul; 12(7):689-93. PubMed ID: 7403238
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of lergotrile on 3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain.
    Fuller RW; Perry KW
    J Neural Transm; 1978; 42(1):23-35. PubMed ID: 641542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical stimulation of the median eminence in rats, changes in catecholamine content and in plasma prolactin and growth hormone concentrations.
    Fekete MI; Herman JP; Kanyicska B; Makara GB
    Life Sci; 1980 Sep; 27(11):929-33. PubMed ID: 7432096
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of amphetamine, fenfluramine and norfenfluramine stereoisomers on the increase of striatum homovanillic acid in rats.
    Jori A; Dolfini E; Tognoni G; Garattini S
    J Pharm Pharmacol; 1973 Apr; 25(4):315-8. PubMed ID: 4146684
    [No Abstract]   [Full Text] [Related]  

  • 14. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
    Invernizzi R; Kmieciak-Kolada K; Samanin R
    Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the l isomer of fenfluramine on dopamine mechanisms in rat brain: further studies.
    Invernizzi R; Bertorelli R; Consolo S; Garattini S; Samanin R
    Eur J Pharmacol; 1989 May; 164(2):241-8. PubMed ID: 2759175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain.
    Borsini F; Bendotti C; Aleotti A; Samanin R; Garattini S
    Pharmacol Res Commun; 1982 Jul; 14(7):671-8. PubMed ID: 6215652
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of norfenfluramine and two structural analogues on brain 5-hydroxyindoles and serum prolactin in rats.
    Fuller RW; Snoddy HD; Clemens JA; Molloy BB
    J Pharm Pharmacol; 1982 Jul; 34(7):449-50. PubMed ID: 6181246
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of penfluridol on circling behavior and striatal DOPAC and serum prolactin concentrations in the rat.
    Annunziato LA; Wuerthele SM; Moore KE
    Eur J Pharmacol; 1978 Aug; 50(3):187-92. PubMed ID: 567584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-dihydroxyphenylacetic acid content of sympathetic ganglia as a possible biochemical indicator of small intensely fluorescent cell participation in ganglionic transmission.
    Karoum F; Speciale SG; Neff NH
    Biochem Pharmacol; 1980 Jan; 29(1):118-9. PubMed ID: 6244826
    [No Abstract]   [Full Text] [Related]  

  • 20. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    Schmidt CJ; Black CK; Taylor VL
    Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.